Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2025)

Arcturus Therapeutics Holdings' Other Working Capital Changes history spans 8 years, with the latest figure at -$2.8 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 94.67% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$23.9 million, up 56.76%, while the annual FY2025 figure was -$23.9 million, 56.76% up from the prior year.
  • Other Working Capital Changes reached -$2.8 million in Q4 2025 per ARCT's latest filing, up from -$16.9 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $31.0 million in Q3 2024 to a low of -$52.6 million in Q4 2024.
  • Average Other Working Capital Changes over 5 years is -$5.0 million, with a median of -$2.5 million recorded in 2024.
  • The largest YoY upside for Other Working Capital Changes was 2042.09% in 2023 against a maximum downside of 2859.46% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$3.7 million in 2021, then tumbled by 353.11% to -$16.6 million in 2022, then skyrocketed by 77.33% to -$3.8 million in 2023, then plummeted by 1300.24% to -$52.6 million in 2024, then skyrocketed by 94.67% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Other Working Capital Changes are -$2.8 million (Q4 2025), -$16.9 million (Q3 2025), and -$2.9 million (Q2 2025).